Two Sigma Advisers
LJPC

Two Sigma Advisers’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Two Sigma Advisers’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-34,900
Closed -$149K – 3019
2022
Q1 		$149K Sell
34,900
-25,436
-42% -$111K ﹤0.01% 2435
2021
Q4 		$281K Sell
60,336
-66,023
-52% -$275K ﹤0.01% 2165
2021
Q3 		$504K Sell
126,359
-2,000
-2% -$7.94K ﹤0.01% 1921
2021
Q2 		$549K Sell
128,359
-176,700
-58% -$757K ﹤0.01% 1913
2021
Q1 		$1.29M Buy
305,059
+1,800
+0.6% +$9.92K ﹤0.01% 1506
2020
Q4 		$1.18M Sell
303,259
-8,600
-3% -$36.8K ﹤0.01% 1488
2020
Q3 		$1.26M Sell
311,859
-63,364
-17% -$262K ﹤0.01% 1397
2020
Q2 		$1.6M Buy
+375,223
New +$2.28M ﹤0.01% 1321

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KT
Kevin Tang $783 AUM 75.59% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Two Sigma Advisers's LJPC Position: Q2 2022 in Review

Two Sigma Advisers sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2022, closing a stake of 34,900 shares — an estimated $149K sold.

Two Sigma Advisers first reported a position in LJPC in Q2 2020 and held it in 8 quarters. The position peaked at $1.6M in Q2 2020. 41 funds tracked by Wall St. Rank hold LJPC as of Q2 2022.

  • Two Sigma Advisers reported no remaining La Jolla Pharmaceutical Company position as of Q2 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 34,900 La Jolla Pharmaceutical Company shares in Q2 2022, an estimated $149K.
  • Two Sigma Advisers first reported a position in La Jolla Pharmaceutical Company in Q2 2020 and held it in 8 quarters.
  • Two Sigma Advisers's La Jolla Pharmaceutical Company position peaked at $1.6M in Q2 2020.
  • 41 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2022.

Based on Two Sigma Advisers's 13F filing for Q2 2022, filed 15 Aug 2022.